サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1766585

ロペラミド塩酸塩市場：製剤別、タイプ別、投与経路別、容量別、薬剤タイプ別、用途別、年齢層別、流通チャネル別、地域別

Loperamide Hydrochloride Market, By Formulation, By Type, By Route of Administration, By Strength, By Medication Type, By Application, By Age Group, By Distribution Channel, By Geography

出版日
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
ロペラミド塩酸塩市場：製剤別、タイプ別、投与経路別、容量別、薬剤タイプ別、用途別、年齢層別、流通チャネル別、地域別
出版日: 2025年06月11日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ロペラミド塩酸塩市場は、2025年には35億2,000万米ドルと推定され、2032年には52億1,000万米ドルに達すると予測され、2025年から2032年までのCAGRは5.75%で成長すると予測されています。

レポート範囲 レポート詳細
基準年 2024 2025年の市場規模 35億2,000万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間：2025年～2032年CAGR： 5.75% 2032年の価値予測 52億1,000万米ドル

ロペラミド塩酸塩の世界市場は、下痢の有病率の増加と効果的なOTC（一般用医薬品）止瀉薬の需要の高まりにより、近年著しい成長を遂げています。合成ピペリジン誘導体であるロペラミド塩酸塩は、腸の運動を鈍らせ、水分と電解質の喪失を抑える作用があるため、下痢止め薬として広く使用されています。市場の拡大には、特に下痢性疾患が公衆衛生上の大きな懸念事項であり続ける新興諸国において、適切な下痢管理の重要性に対する認識が高まっていることがさらに拍車をかけています。さらに、ロペラミド塩酸塩ジェネリック製品の入手可能性が高まっていることや、主要市場企業の流通網が拡大していることも、市場拡大に寄与しています。効果的で手ごろな価格の下痢止め治療薬に対する需要が高まり続けていることから、ロペラミド塩酸塩の世界市場は今後数年間で安定した成長を遂げるものと思われます。

市場力学：

ロペラミド塩酸塩の世界市場は、特に新興諸国における下痢性疾患の有病率の高さ、市販の止瀉薬に対する需要の増加など、いくつかの要因によって牽引されています。適切な下痢管理の重要性に対する意識の高まりや、新興国におけるヘルスケア支出の増加も市場の成長に寄与しています。しかし、代替の下痢止め治療薬があることや、便秘や腹痛などロペラミド塩酸塩に関連する副作用の可能性など、市場は一定の抑制要因に直面しています。さらに、特定の地域では適切なヘルスケアインフラが整備されておらず、医療施設へのアクセスが限られていることも、市場の成長を阻害する可能性があります。このような課題にもかかわらず、ロペラミド塩酸塩ジェネリック製品に対する需要の増加、主要市場企業の流通網の拡大、止瀉薬の有効性と安全性を向上させるための研究開発活動への注目の高まりが、市場の成長機会を大きく後押ししています。さらに、セルフメディケーションの増加傾向やオンライン薬局の人気の高まりは、今後数年間で市場拡大の新たな道を開くと予想されます。

本調査の主な特徴

  • 当レポートでは、世界のロペラミド塩酸塩市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模（億米ドル）と年間複合成長率（CAGR%）を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界のロペラミド塩酸塩市場の主要企業をプロファイルしています。
  • 本レポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にするでしょう。
  • この調査レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
  • 利害関係者は、世界のロペラミド塩酸塩市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界のロペラミド塩酸塩市場、製剤別、2020年～2032年

  • 錠剤
  • カプセル
  • 経口溶液/液体
  • その他

第5章 世界のロペラミド塩酸塩市場、タイプ別、2020年～2032年

  • 純度99%以上
  • 純度99%以下

第6章 ロペラミド塩酸塩の世界市場、投与経路別、2020年～2032年

  • 経口
  • 非経口

第7章 世界のロペラミド塩酸塩市場、容量別、2020年～2032年

  • 2mg
  • 1mg/5mL
  • 1mg/7.5mL
  • 2mg/15mL
  • その他

第8章 世界のロペラミド塩酸塩市場、薬剤タイプ別、2020年～2032年

  • 市販薬（OTC）
  • 処方箋

第9章 ロペラミド塩酸塩の世界市場、用途別、2020年～2032年

  • 急性下痢
  • 慢性下痢
  • 過敏性腸症候群（IBS）
  • その他の胃腸疾患

第10章 世界のロペラミド塩酸塩市場、年齢層別、2020年～2032年

  • 小児科
  • 成人
  • 高齢者

第11章 世界のロペラミド塩酸塩市場、流通チャネル別、2020年～2032年

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第12章 世界のロペラミド塩酸塩市場、地域別、2020年～2032年

  • 北米
      • 米国
      • カナダ
  • ラテンアメリカ
      • ブラジル
      • アルゼンチン
      • メキシコ
      • その他ラテンアメリカ
  • 欧州
      • ドイツ
      • 英国
      • スペイン
      • フランス
      • イタリア
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋地域
  • 中東
      • GCC諸国
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 北アフリカ
      • 中央アフリカ

第13章 競合情勢

  • Johnson & Johnson
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Cipla Limited
  • Lupin Pharmaceuticals
  • Amgen Inc.
  • Novartis AG
  • Pfizer Inc.
  • GSK（GlaxoSmithKline）
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Sanofi S.A.
  • Bayer AG

第14章 アナリストの推奨事項

  • 機会
  • アナリストの見解
  • Coherent Opportunity Map

第15章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI8072

Loperamide Hydrochloride Market is estimated to be valued at USD 3.52 Bn in 2025 and is expected to reach USD 5.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.75% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.52 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.75% 2032 Value Projection: USD 5.21 Bn

The global loperamide hydrochloride market has witnessed significant growth in recent years, driven by the increasing prevalence of diarrhea and the rising demand for effective over-the-counter (OTC) antidiarrheal medications. Loperamide hydrochloride, a synthetic piperidine derivative, is widely used as an antidiarrheal agent due to its ability to slow down intestinal motility and reduce fluid and electrolyte loss. The market's expansion is further fueled by the growing awareness about the importance of proper diarrhea management, particularly in developing countries where diarrheal diseases remain a major public health concern. Additionally, the increasing availability of generic loperamide hydrochloride products and the expanding distribution networks of key market players have contributed to the market's growth. As the demand for effective and affordable antidiarrheal treatments continues to rise, the global loperamide hydrochloride market is poised for steady growth in the coming years.

Market Dynamics:

The global loperamide hydrochloride market is driven by several factors, including the high prevalence of diarrheal diseases, particularly in developing countries, and the increasing demand for over-the-counter antidiarrheal medications. The growing awareness about the importance of proper diarrhea management and the rising healthcare expenditure in emerging economies also contribute to the market's growth. However, the market faces certain restraints, such as the availability of alternative antidiarrheal treatments and the potential side effects associated with loperamide hydrochloride, such as constipation and abdominal pain. Additionally, the lack of proper healthcare infrastructure and limited access to medical facilities in certain regions may hinder the market's growth. Despite these challenges, the market presents significant opportunities for growth, driven by the increasing demand for generic loperamide hydrochloride products, the expanding distribution networks of key market players, and the growing focus on research and development activities to improve the efficacy and safety of antidiarrheal medications. Moreover, the rising trend of self-medication and the increasing popularity of online pharmacies are expected to create new avenues for market expansion in the coming years.

Key Features of the Study:

  • This report provides in-depth analysis of the global loperamide hydrochloride market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global loperamide hydrochloride market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Cipla Limited, Lupin Pharmaceuticals, Amgen Inc., Novartis AG, Pfizer Inc., GSK (GlaxoSmithKline), Merck & Co., Inc., AbbVie Inc., Sanofi S.A., and Bayer AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global loperamide hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global loperamide hydrochloride market

Market Segmentation

  • Formulation Insights (Revenue, USD Bn, 2020 - 2032)
    • Tablet
    • Capsule
    • Oral Solution/Liquid
    • Others
  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Purity Above 99%
    • Purity Below 99%
  • Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
    • Oral
    • Parenteral
  • Strength Insights (Revenue, USD Bn, 2020 - 2032)
    • 2 mg
    • 1 mg/5 mL
    • 1 mg/7.5 mL
    • 2 mg/15 mL
    • Others
  • Medication Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Over-the-Counter (OTC)
    • Prescription
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Acute Diarrhea
    • Chronic Diarrhea
    • Irritable Bowel Syndrome (IBS)
    • Other Gastrointestinal Disorders
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Pediatric
    • Adult
    • Geriatric
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Johnson & Johnson
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Cipla Limited
    • Lupin Pharmaceuticals
    • Amgen Inc.
    • Novartis AG
    • Pfizer Inc.
    • GSK (GlaxoSmithKline)
    • Merck & Co., Inc.
    • AbbVie Inc.
    • Sanofi S.A.
    • Bayer AG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Loperamide Hydrochloride Market, By Formulation
    • Global Loperamide Hydrochloride Market, By Type
    • Global Loperamide Hydrochloride Market, By Route of Administration
    • Global Loperamide Hydrochloride Market, By Strength
    • Global Loperamide Hydrochloride Market, By Medication Type
    • Global Loperamide Hydrochloride Market, By Application
    • Global Loperamide Hydrochloride Market, By Age Group
    • Global Loperamide Hydrochloride Market, By Distribution Channel
    • Global Loperamide Hydrochloride Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Loperamide Hydrochloride Market, By Formulation, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Capsule
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oral Solution/Liquid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Loperamide Hydrochloride Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Purity Above 99%
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Purity Below 99%
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Loperamide Hydrochloride Market, By Route of Administration, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Loperamide Hydrochloride Market, By Strength, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 2 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 1 mg/5 mL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 1 mg/7.5 mL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 2 mg/15 mL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Loperamide Hydrochloride Market, By Medication Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Over-the-Counter (OTC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prescription
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Loperamide Hydrochloride Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Acute Diarrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chronic Diarrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Irritable Bowel Syndrome (IBS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Loperamide Hydrochloride Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Loperamide Hydrochloride Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Loperamide Hydrochloride Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Medication Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Medication Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Medication Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Medication Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Medication Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Medication Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

13. Competitive Landscape

  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aurobindo Pharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cipla Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lupin Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GSK (GlaxoSmithKline)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

14. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

15. References and Research Methodology

  • References
  • Research Methodology
  • About us